EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lipidomes of placenta-derived extracellular vesicles reveal disrupted metabolic adaptation in type 1 diabetes

Miira M Klemetti, Jiayi Li, Sruthi Alahari, Ante B V Pettersson, Denice Feig, Helen R Murphy, Martin Post iD, Hannes Röst iD, Isabella Caniggia iD

The Journal of Clinical Endocrinology & Metabolism · 30.10.2026

DOI: 10.1210/clinem/dgag411 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 30.10.2026. Verfasst von Miira M Klemetti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Sinai Health System, Toronto, ON M5G 1X5, Canada. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, CIHR, Canada Research Chair Tier1.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Placental metabolic adaptation is dynamically orchestrated across gestation to support fetal development, yet how this process is disrupted in type 1 diabetes (T1D) and contributes to altered fetal metabolic outcomes remains unclear. Small extracellular vesicles (sEVs) may provide a minimally invasive window into placental metabolic state during pregnancy.

Objective

To determine whether lipidomic profiling of placental sEVs (P-sEVs) in maternal circulation captures dynamic placental metabolic adaptation and its dysregulation in T1D pregnancy. Design and Setting Prospective longitudinal cohort study conducted within the Ontario Birth Study and the Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes (CONCEPTT) study.

Participants

Maternal plasma samples were collected across gestation (10-14, 24-32, and 34-40 weeks of gestation) from 200 normoglycemic pregnancies and 151 pregnancies from individuals with preexisting T1D.

Methods

Placental sEVs were isolated and characterized, and lipid composition was quantified using shotgun mass spectrometry–based lipidomics. Multivariate and machine learning approaches were applied to define gestational lipid trajectories and assess associations with fetal metabolic outcomes. Main Outcome Measures Gestational lipid trajectories in P-sEVs from normoglycemic and T1D, and their association with maternal and fetal risk factors and clinical outcomes.

Results

Placental sEVs from T1D pregnancies exhibited increased vesicle size and reduced abundance. Lipidomic profiling revealed divergence in the magnitude, direction, and timing of gestational lipid trajectories compared with controls. Lipid species involved in membrane remodeling and bioactive signaling distinguished pregnancies with high vs low cord blood C-peptide, a marker of fetal endogenous insulin secretion, with strong discrimination (area under the characteristic curve = 0.85).

Conclusion

Circulating P-sEV lipid profiles reflect disrupted placental metabolic adaptation in T1D pregnancy and are associated with fetal hyperinsulinemia at birth, supporting their potential for minimally invasive assessment of placental function.

Schlagwörter

Stichwörter der Autor:innen

fetal hyperinsulinemialipidomicsplacentapregnancysmall extracellular vesiclestype 1 diabetes

Autor:innen und Institutionen

  • Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Sinai Health System, Toronto, ON M5G 1X5, Canada.
  • Department of Obstetrics and Gynaecology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5G 1E2, Canada.
  • Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 2, FI-00029 HUS, Helsinki, Finland.
  • Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON M5S 3E1, Canada.
  • Program in Translational Medicine, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
  • Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada.

ORCID-Profile: Martin Post, Hannes Röst, Isabella Caniggia

Förderung

  • NIH HHS
  • CIHR
  • Canada Research Chair Tier1
  • National Institutes of Health
  • Canadian Institutes of Health Research

Zitieren

APA

Klemetti, M. M., Li, J., Alahari, S., Pettersson, A. B. V., Feig, D., Murphy, H. R., Post, M., Röst, H., & Caniggia, I. (2026). Lipidomes of placenta-derived extracellular vesicles reveal disrupted metabolic adaptation in type 1 diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag411

Vancouver

Klemetti MM, Li J, Alahari S, Pettersson ABV, Feig D, Murphy HR, et al. Lipidomes of placenta-derived extracellular vesicles reveal disrupted metabolic adaptation in type 1 diabetes. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag411

BibTeX
@article{Klemetti2026,
  author = {Klemetti, Miira M and Li, Jiayi and Alahari, Sruthi and Pettersson, Ante B V and Feig, Denice and Murphy, Helen R and Post, Martin and Röst, Hannes and Caniggia, Isabella},
  title = {Lipidomes of placenta-derived extracellular vesicles reveal disrupted metabolic adaptation in type 1 diabetes},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgag411}
}
Kostenlos starten →